Faraz Kazmi

5PUBLICATIONS
1CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesCross-sectional analysisGlycoconjugatesMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 04, 2018
Characterization of the In Vitro Inhibitory Potential of the Oligonucleotide Imetelstat on Human Cytochrome P450 Enzymes with Predictions of In Vivo Drug-Drug Interactions.

Faraz Kazmi, Carlo Sensenhauser, Tony Greway

|May 09, 2018
An Assessment of the In Vitro Inhibition of Cytochrome P450 Enzymes, UDP-Glucuronosyltransferases, and Transporters by Phosphodiester- or Phosphorothioate-Linked Oligonucleotides.

Faraz Kazmi, Phyllis Yerino, Chase McCoy

|Sep 11, 2015
The Reliability of Estimating Ki Values for Direct, Reversible Inhibition of Cytochrome P450 Enzymes from Corresponding IC50 Values: A Retrospective Analysis of 343 Experiments.

Lois J Haupt, Faraz Kazmi, Brian W Ogilvie

|Jan 18, 2015
A long-standing mystery solved: the formation of 3-hydroxydesloratadine is catalyzed by CYP2C8 but prior glucuronidation of desloratadine by UDP-glucuronosyltransferase 2B10 is an obligatory requirement.

Faraz Kazmi, Joanna E Barbara, Phyllis Yerino

|Oct 19, 2014
Anti-CD28 monoclonal antibody-stimulated cytokines released from blood suppress CYP1A2, CYP2B6, and CYP3A4 in human hepatocytes in vitro.

Maciej Czerwiński, Faraz Kazmi, Andrew Parkinson

Pageof 1

Frequent Collaborators

2 joint publications

Brian W Ogilvie